Back
BioProcess International - CEPI and Samsung Biologics Partner
webbioprocessintl.com·bioprocessintl.com/global-markets/cepi-and-samsung-biolog...
This resource covers a biopharma industry partnership for pandemic preparedness and has minimal direct relevance to AI safety topics; it may be tangentially relevant to global catastrophic risk coordination discussions.
Metadata
Importance: 12/100news articlenews
Summary
CEPI and Samsung Biologics have formed a partnership with a $20 million initial budget to strengthen vaccine manufacturing preparedness, particularly for low- and middle-income countries. Samsung Biologics joins CEPI's Vaccine Manufacturing Facility Network as its first East Asian partner, focusing on scalable recombinant-protein vaccine manufacturing using mammalian cell-based infrastructure. The collaboration supports CEPI's 100 Days Mission to enable rapid vaccine deployment against future pandemic threats.
Key Points
- •Samsung Biologics becomes CEPI's first East Asian manufacturing partner, joining organizations from Brazil, India, Indonesia, South Africa, and Senegal in the VMFN.
- •Partnership backed by an initial $20 million budget to develop scalable recombinant-protein vaccine manufacturing processes.
- •Supports CEPI's 100 Days Mission: building infrastructure to develop and deploy vaccines within 100 days of a new pandemic threat.
- •Focus on improving vaccine access and manufacturing capacity in low- and middle-income countries (LMICs).
- •Leverages Samsung's mammalian cell-based infrastructure for rapid scaling in response to emerging viral threats.
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| Coalition for Epidemic Preparedness Innovations | Organization | 53.0 |
Cached Content Preview
HTTP 200Fetched Mar 20, 202618 KB
- [Global Markets](https://www.bioprocessintl.com/bioprocess-insider/global-markets)
- [Vaccines](https://www.bioprocessintl.com/therapeutic-modalities/vaccines)
- [Deal-Making](https://www.bioprocessintl.com/bioprocess-insider/deal-making)
- [Facilities & Capacity](https://www.bioprocessintl.com/bioprocess-insider/facilities-capacity)
- [News](https://www.bioprocessintl.com/latest-news)
[](https://www.bioprocessintl.com/program/bioprocess-insider)
# CEPI and Samsung Biologics partner to enhance global vaccine access
The collaboration advances CEPI’s pandemic-preparedness agenda.
[](https://www.bioprocessintl.com/author/josh-abbott)
[Josh Abbott,](https://www.bioprocessintl.com/author/josh-abbott) Editor, BioProcess Insider
February 3, 2026
2 Min Read
stock.adobe.com
[Linkedin](https://www.linkedin.com/sharing/share-offsite/?url=https://www.bioprocessintl.com/global-markets/cepi-and-samsung-biologics-partner-to-enhance-global-vaccine-access)[Twitter](http://www.twitter.com/intent/tweet?url=https://www.bioprocessintl.com/global-markets/cepi-and-samsung-biologics-partner-to-enhance-global-vaccine-access)[Email](mailto:?subject=CEPI%20and%20Samsung%20Biologics%20partner%20to%20enhance%20global%20vaccine%20access&body=I%20thought%20the%20following%20from%20BioProcess%20International%20might%20interest%20you.%0D%0A%0D%0A%20CEPI%20and%20Samsung%20Biologics%20partner%20to%20enhance%20global%20vaccine%20access%0D%0Ahttps%3A%2F%2Fwww.bioprocessintl.com%2Fglobal-markets%2Fcepi-and-samsung-biologics-partner-to-enhance-global-vaccine-access)
Contract development and manufacturing organization (CDMO) Samsung Biologics has [partnered](https://prnmedia.prnewswire.com/news-releases/cepi-and-samsung-biologics-collaborate-to-strengthen-outbreak-ready-vaccine-production-and-global-access-302677348.html) with the vaccine research and development foundation Coalition for Epidemic Preparedness Innovations (CEPI) to strengthen vaccine manufacturing preparedness in low- and middle-income countries (LMICs).
South Korea-based Samsung Biologics will join CEPI’s Vaccine Manufacturing Facility Network (VMFN), becoming CEPI’s first East Asian manufacturing partner. It joins organizations based in Brazil, India, Indonesia, South Africa, and Senegal. The addition of Samsung advances CEPI’s mission of strengthening its manufacturing footpri
... (truncated, 18 KB total)Resource ID:
4fdf27f4683a1dae | Stable ID: MmIzNDgzNm